OR7E86P

Across TCGA pan-cancer cohorts, OR7E86P RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated OR7E86P data layer.

The strongest signal is observed in lymphoid neoplasm diffuse large b-cell lymphoma (DLBC), where higher OR7E86P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR7E86P expression acts as an unfavorable survival marker, although some lineages such as HNSC show a favorable association.

DLBC, HNSC, and UCEC are the cancer types where OR7E86P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
DLBC	DFS	Tertile	IV	0.120	0.683	.001	36	view →
HNSC	DFS	Tertile	All	0.658	0.312	.014	36	view →
UCEC	DFS	Tertile	II,III,IV	0.710	0.835	.015	36	view →
COAD	DFS	Tertile	II,III,IV	0.549	0.767	.002	30	view →
LGG	OS	Tertile	All	0.183	0.525	.014	18	view →
PCPG	DFS	Tertile	All	0.512	0.936	<.001	18	view →
LIHC	OS	Tertile	All	0.378	0.787	.008	9	view →
SKCM	OS	Tertile	II,III,IV	0.116	0.394	.034	6	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

OR7E86P–DLBC (DFS)

Open the DLBC breakdown →